Skip to main content

Table 3 Correlation between total number of PCR-positive assays and rates of progression disease or median survivals

From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

No. of positive assays

No. of patients

No. of PDs (%)

median DFS (months)

median OS (months)

0

18

3 (17)

81

83

1

46

8 (17)

81

83

2

45

12 (27)

82

83

3

27

17 (63)

78

79

4–5

13

9 (69)

66

70

  1. PD, progression disease; DFS, disease free-survival; OS, overall survival